Clinical & Interventional Cardiology - 2019 President: Michele M. Gulizia, MD, FACC, FESC - International Society of ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CATANIA APRIL 13-15 ITALY
2019
Clinical &
Interventional
Cardiology
President:
Michele M. Gulizia, MD, FACC, FESC
1
MCM 2019 first 12pag 0718 GB OK.indd 1 07/08/18 09.40
Scientific Committee*
Eugene Braunwald (USA) Bulent Gorenek (Turkey) Marc Pfeffer (USA)
Joseph Brugada (Spain) Michele M. Gulizia (Italy) Antonio Raviele (Italy)
Riccardo Cappato (Italy) Ciro Indolfi (Italy) Massimo Santini (Italy)
Paul Casale (USA) Aldo P. Maggioni (Italy) Luigi Tavazzi (Italy)
Leonardo De Luca (Italy) Attilio Maseri (Italy) Michael Valentine (USA)
Giuseppe Di Pasquale (Italy) Andrea Natale (USA)
Organizing Committee*
Michele M. Gulizia Giuseppe Di Dio Gaetano Placenti
Mario Audoly Giuseppe Di Guardo Anna Portale
Ilaria Cantarella Agatino Diolosà Salvatore Raciti
Rosario Cardillo Daniele Galatà Natala Savoca
Anna Maria Castorina Damiana Fiscella Giuseppa Sciuto
Angelo Luca Corso Alessandro Fontana Cinzia Scuderi
Francesca Currenti Giuseppina Maura Francese Serena Tipo
Enza Luciana D’Agostino Giuditta Gianì Gaetano Todero
Cardiology Division - Garibaldi - Nesima Hospital - Catania, Italy
Advisory Board*
Maurizio G. Abrignani (Italy) Silvia Favilli (Italy) Leonardo Patanè (Italy)
Gianfranco Alunni (Italy) Claudio Ferri (Italy) Roberto Pedretti (Italy)
Giuseppe Ambrosio(Italy) Giuseppina Maura Francese (Italy) Pasquale Perrone Filardi (Italy)
Antonio F. Amico (Italy) Claudio Fresco (Italy) Francesco Perticone (Italy)
Vincenzo Amodeo (Italy) Francesco Gabbrielli (Italy) Marc Pfeffer (USA)
Luigi Aquilanti (Italy) Domenico Gabrielli (Italy) Paolo G. Pino (Italy)
Nadia Aspromonte (Italy) Angelo Gambera (Italy) Fausto J. Pinto (Portogallo)
Cesare Baldi (Italy) Gianfranco Gensini (Italy) Calogero Puntrello (Italy)
Umberto Berrettini (Italy) Giovanna Geraci (Italy) Enrico Pusineri (Italy)
Edoardo Bonsante (Italy) Bulent Gorenek (Turkey) Serena Rakar (Italy)
Giuseppe Boriani (Italy) Giovanni Gregorio (Italy) Antonio Raviele (Italy)
Marco Botta (Italy) Massimo Grimaldi (Italy) Renato Pietro Ricci (Italy)
Eugene Braunwald (USA) Gabriele Guardigli (Italy) Carmine Riccio (Italy)
Joseph Brugada (Spain) Michele M. Gulizia (Italy) Carla Riganti (Italy)
Giacinto Calculli (Italy) Massimo Imazio (Italy) Francesco Romeo (Italy)
Pasquale Caldarola (Italy) Ciro Indolfi (Italy) Loris Roncon (Italy)
Roberto Caporale (Italy) Fabiana Lucà (Italy) Giuseppe Rosano (Italy)
Riccardo Cappato (Italy) Maurizio Lunati (Italy) Roberta Rossini (Italy)
Alessandro Carbonaro (Italy) Aldo Pietro Maggioni (Italy) Andrea Rubboli (Italy)
Paul Casale (USA) Attilio Maseri (Italy) Maria G. Russo (Italy)
Giancarlo Casolo (Italy) Giuseppe Mercuro (Italy) Massimo Santini (Italy)
Domenico Catanzariti (Italy) Vincenzo Montemurro (Italy) Maurizio Santomauro (Italy)
Roberto Ceravolo (Italy) Loredana Morichelli (Italy) Fortunato Scotto di Uccio (Italy)
Giacomo Chiarandà (Italy) Ernesto Mossuti (Italy) Gianfranco Sinagra (Italy)
Mario Chiatto (Italy) Adriano Murrone (Italy) Corrado Tamburino (Italy)
Manlio Cipriani (Italy) Francesco Musumeci (Italy) Giuseppe Tarantini (Italy)
Furio Colivicchi (Italy) Giuseppe Musumeci (Italy) Pier Luigi Temporelli (Italy)
Marco Corda (Italy) Cosimo Napoletano (Italy) Sakis Themistoclakis (Italy)
Raffaele De Caterina (Italy) Federico Nardi (Italy) Luigi Tavazzi (Italy)
Pietro Delise (Italy) Andrea Natale (USA) Stefano Urbinati (Italy)
Giovanni De Luca (Italy) Salvatore Novo (Italy) Ugo Vairo (Italy)
Leonardo De Luca (Italy) Fabrizio Oliva (Italy) Serafina Valente (Italy)
Stefania A. Di Fusco (Italy) Giuseppe Pajes(Italy) Michael Valentine (USA)
Andrea Di Lenarda (Italy) Giuseppe Palazzo (Italy) Marina Angela Viccione (Italy)
Giuseppe Di Pasquale (Italy) Vittorio Panno (Italy) Maurizio Volterrani (Italy)
Giuseppe Di Tano (Italy) Alessandro Parolari (Italy) Giovanni Battista Zito (Italy)
Stefano Domenicucci (Italy) Iris Parrini (Italy) Guerrino Zuin (Italy)
Allied Professionals Course Coordinators*
Giuseppina Maura Francese (Italy) Angelo Gambera (Italy) Loredana Morichelli (Italy)
*updated 26 July 2018
2
MCM 2019 first 12pag 0718 GB OK.indd 2 07/08/18 09.40
CATANIA APRIL 13-15 ITALY
2019
Dear Colleagues and Friends,
I am pleased to invite you to attend the 9th edition of the Mediterranean Cardiology Mee-
ting (MCM), April 13 - 15, 2019 in Catania (Italy).
Over 1500 participants took part in the last edition with strong international attendance, which confirmed
the high interest aroused by this biannual event.
An outstanding Faculty, selected from the leading experts on these fields, will provide the highest quality
training, through innovative interactive programs and happenings; joint sessions will be organized with the
contribution of: American College of Cardiology, Chapters of the American College of Cardiology, Scientific
Societies of Cardiology and General Medicine.
Thanks to multidisciplinary Courses, Symposia, Debates on Controversial Topics, Clinical Tutorials, Luncheon
Panels, Focus on, Meet-the-Expert Sessions, Interactive Case Reviews, Interactive Sessions, Intercultural
Exchanges,Abstract and Poster Sessions, the meeting will investigate the current state and the prospective
developments for the treatment of:Atrial Fibrillation, Sudden Cardiac Death, Heart Failure,Acute Coronary
Syndromes, Global Cardiovascular Prevention, Arterial Hypertension, Pharmacological Therapy, Syncope,
Congenital Heart Disease, Cardiac Monitoring Technologies and Genetics.
A major innovation is represented by the CARDIOCONTEST sessions, where the use of Virtual Clinical
simulators will allow attendees to practise and improve their clinical skills, in order to deal with a wide
range of cardiac problems.
Cardiologists, internists, ER physicians, general practitioners, nurses and healthcare technicians with a keen
interest in the whole management process of heart diseases will be able to find a knowledge-intensive
program, as MCM has been providing for years a valuable opportunity for an update on Clinical and
Interventional Cardiology.
Catania, as one of the most famous historical and cultural locations in the whole Mediterranean area, is
the ideal setting for this meeting. It is a particularly lively and fascinating town, rich in marvellous examples
of typically Sicilian baroque style, as well as one of the main economic and educational centres in the island,
and a key hub of the technological industry.This beautiful city,
full of colours, fragrances and flavours, is suspended between
the deep blue of the Ionian Sea and the majestic shape of
Etna volcano, which dominates the town from afar.
Looking forward to meeting you in Catania, sincerely
Michele M. Gulizia, MD, FACC, FESC
Mediterranean Cardiology Meeting President
3
MCM 2019 first 12pag 0718 GB OK.indd 3 07/08/18 09.40
CATANIA APRIL 13-15 ITALY
2019
4
MCM 2019 first 12pag 0718 GB OK.indd 4 07/08/18 09.40
MAIN TOPICS
CLINICAL CARDIOLOGY
• Epidemiology and risk stratification in healthy and sick population
• Expanding the target population for anti-platelet/coagulation therapy
• Controversial issues: from clinical studies to real life
• Sport and cardiac pathologies
• Nuclear cardiology in CAD and CHF patients
Acute Coronary Syndromes
• Evolving therapies for Acute myocardial Infarction: when PTCA, when
stent?
• Hybrid myocardial revascularization
• Post-ACS patient’s route
• Anti-thrombotic therapy in STEMI and NSTEMI patient
• Management of STEMI and non-STEMI patient
• New antiplatelet drugs
• BioResorbable Vascular Scaffold update in interventional cardiology
• Spinal Cord Stimulation in refractory CAD: still an appropriate choice?
• Chronic Ischemic artery disease: dignaostic pathways and therapeutical
algorythms
Global Cardiovascular Risk Prevention
• Global Cardiovascular Risk assessment and prevention
• Insulin Resistance Syndrome, type 2 Diabetes and Atherosclerosis: an
explosive mixture
• Lipid-lowering therapy: do we need statins for all life long?
• Diagnosis and treatment of patients with hypercholesterolemia : update
• New drugs for treating resistant hypercholesterolemia
• PCSK9i and clinical outcomes
• Role of platelets in the atherosclerosis pathogenesis
• Drug interaction, gender, age and comorbidities
• Elderly and Cardiology: are all patients to be treated the same way?
• Right pharmacological therapy in fragile patient
5
MCM 2019 first 12pag 0718 GB OK.indd 5 07/08/18 09.40
CATANIA APRIL 13-15 ITALY
2019
Echocardiography & Imaging
• Echocardiography in the evaluation of the induced AF-mechanical
remodelling
• Evaluation of thromboembolic atrial sources
• Echo optimisation of atrial-ventricular delay in paced AF patients
• Doppler echocardiography in the management of the resynchronization
in HF
• Consensus Documents on Imaging and coronary anatomy
Heart Failure
• The interaction of AF and CHF and its clinical implications
• Neurohumoral activation in CHF patients
• Latest pharmacological therapy for CHF
• The HF doctor: is there still a role for clinical cardiologists?
• What lessons from the early completed trials?
• Management of hypertrophic and dilated cardiomyopathy
• Biomarkers inHF
• Management and diagnostic pathways for HF ambulatory network
Non-Invasive Risk Stratification
• New non-invasive markers for risk stratification
Syncope
• Syncope: practical issues of diagnosis and treatment
• Physical treatment of neurally-mediated syncope
• Organizational models of Syncope Unit
• Modern management of chest pain and unexplained palpitations
• The new generation implantable loop recorders
6
MCM 2019 first 12pag 0718 GB OK.indd 6 07/08/18 09.40
MAIN TOPICS
Hypertrophic Cardiomyopathy
New Guidelines in Cardiology
CLINICAL ARRHYTHMOLOGY
Atrial Fibrillation
• New insight into the electrophysiological mechanism of AF initiation and
perpetuation
• The ionic bases underlying the trigger of AF
• Atrial Fibrillation
• New experimental drugs for the treatment of recurrent AF
• Limitations of current guidelines for anticoagulation in AF
• The prevalence and clinical significance of silent AF
• Role of drug therapy in the prevention of recurrence of AF
• New drugs for stroke prevention
• New oral anticoagulants
• Atrial Fibrillation in children
Sudden Death
• Results of twenty years experience of Cardiac AED Resuscitation
programs
• Advances in the prevention of SCD with non-antiarrhythmic drugs
• Home defibrillation strategy in high risk patients
Genetic Arrhythmias
7
MCM 2019 first 12pag 0718 GB OK.indd 7 07/08/18 09.40
MAIN TOPICS
CATANIA APRIL 13-15 ITALY
2019
INTERVENTIONAL CARDIOLOGY
Trans-Catheter Ablation
SUPRAVENTRICULAR ARRHYTHMIAS
• Efficacy and safety of drug therapy vs trans-catheter ablation for atrial
flutter
• Pulmonary Veins anatomy variability
• Ablation of AF in Pulmonary and Non-Pulmonary Foci
• Cryoablation and circumferential PV isolation: morbidity, mortality, QoL
and long-term outcomes
• The efficacy and safety of the cryosurgical maze procedure for refractory AF
• Ablation of Atrial Flutter
VENTRICULAR ARRHYTHMIAS
• Percutaneous trans-catheter ablation of ventricular arrhythmias
• How to manage non-inducibility
• Setting anti-tachypacing algorithms after ablation
Implantable Pacing Device
• Latest indication to Cardiac Pacing
• Leadless pacemaker
• Left ventricle endocardial cardiac pacing
• New Pacing, Prevention and Cardioversion algorithms
• Latest pacing and ICD leads technology
• Telemedicine for the home follow-up of PM/ICD patients
• New generation of implantable cardiac haemodynamic sensors
• Remote control and telemedicine by implantable device
• MR-conditional pacemaker systems: are they all alike?
• Cost-effectiveness of drug/devices interaction
Heart Failure & Cardiac Resynchronization
• Hybrid therapy in CHF and AF
• The optimal candidates to biventricular pacing
• New-found complications of biventricular pacing
• Optmizing CRT vector selection
• ICD backup in biventricular paced CHF patients need of multiples therapy
in a single device
• Fluid & Congestion monitoring
8
MCM 2019 first 12pag 0718 GB OK.indd 8 07/08/18 09.41
Supraventricular Arrhythmias
• Drug-device interaction in the management of pacing, prevention and
treatment of atrial tachyarrhythmias
• New atrial tachyarrhythmias detection algorithms
Implantable Defibrillators
• Newer-generation ICDs
• Is there a role for atrial ICD or is dual ICD enough?
• New physiological ICD therapies
• Primary Prevention of Sudden Cardiac Death in different population
• Remote monitoring devices
• MR-conditional implantable defibrillators: what makes some of them
really innovative
• The second generation Subcutaneous ICD
Hemodinamical & Surgical Therapies
• New surgical strategies for AF
• Surgical transepicardic approach to CRT
• Role of surgery in end-stage CHF
• The treatment of ischemic mitral valve
• TAVI
• MITRACLIP
• The new mitral and tricuspid endoprosthesis
PEDIATRIC CARDIOLOGY
• Prenatal diagnosis of congenital cardiopathies
• Diagnostic and therapeutical pathways of morecommons congenital
cardiopathies
• The Italian GUCH Registry
• GUCH’ managements in cardiological ambulatories
BASIC CARDIOLOGY & NEW FRONTIERS
• New developments in cardiac imaging
• Data-banks in cardiology: an useful tool in the follow-up
• Genetics, arrhythmogenesis and cardiomyopathies
• Cellular and molecular mechanism of conduction disease and apoptosis
• Late Breaking Trials & Ongoing Trials
9
MCM 2019 first 12pag 0718 GB OK.indd 9 07/08/18 09.41
LOCATION
CATANIA APRIL 13-15 ITALY
2019
CATANIA & CONGRESS VENUE
Catania is undoubtely one of the most important cities in the whole
Mediterranean area, both in terms of cultural and historical point
of view. It is one of the few cities in Italy that offers a variety of
landscapes.
condensed in one site. Located on the east coast of Sicily (which
represents the metropolitan area with the highest population
density), Catania has ancient origins since its foundation
dates back to 729 BC. During its history Catania has been a
constant point of reference for the entire Mediterranean area,
especially from an artistic and cultural point of view: it is here
that in 1434 the oldest university of Sicily was founded. The
remains of several ruins still enrich the heritage of the town and
surrounding areas, despite Catania was repeatedly destroyed by
violent volcanic eruptions caused by the Etna volcano (the most
impressive occurred in 1669) and by devastating earthquakes
(the more catastrophic one occurred in 1693). It is from this
tragic event that the city and its people were able to get up in a
truly unique and admirable way. A work of reconstruction with
few equals in the world led to the blossoming of the famous
“Sicilian Baroque” style of architecture that identifies more than
any other the fantasy, the imaginative power and the passion for
beauty of Catania and its inhabitants.
Therefore in 2006 the splendid baroque center of Catania
became a UNESCO World Heritage Site, along with seven towns
of the Val di Noto, Sicily. Today, Catania is a city full of colors,
scents and flavors - a lively and surprising, suspended between
the magic of the blue Ionian Sea and the imposing outline of
Etna volcano and often snowy, which dominates the city from
above.
10
MCM 2019 first 12pag 0718 GB OK.indd 10 07/08/18 09.41Four Points by Sheraton Catania Hotel & Conference Center
Just few minutes from the historic center of Catania, the Sheraton
Hotel offers high level of hospitality with a wide range of business
and spare time facilities. The Sheraton Catania is one of the largest
conference centers in eastern Sicily, with an area of 724 square meters
in 6 modular meeting rooms of different sizes and acoustically isolated.
All the 162 rooms and 7 suites - walking through a panoramic elevator
- are characterized by colors that come into perfect harmony with the
landscape of the Mediterranean area. Each room is equipped with
all facilities and comforts offering the highest standards of quality
and safety. The conference area, personalized for the Mediterranean
Cardiology Meeting 2019, provides a great learning experience in an
extremely pleasant and comfortable site.
11
MCM 2019 first 12pag 0718 GB OK.indd 11 07/08/18 09.41CATANIA APRIL 13-15 ITALY
2019
ORGANIZED BY
Cardiology Division
“Garibaldi-Nesima” Hospital
SCIENTIFIC SECRETARIAT
Michele M. Gulizia
Cardiology Division
“Garibaldi-Nesima” Hospital
Via Palermo, 636
95122 Catania, Italy
Phone +39 095 7598502
Fax +39 095 7598505
e-mail: michele.gulizia60@gmail.com
CONGRESS VENUE
Four Points by Sheraton Catania
Hotel & Conference Center
ORGANIZING SECRETARIAT
Adria Congrex s.r.l.
Via Sassonia, 30
47922 Rimini, Italy
Phone +39 0541 305811
Fax +39 0541 305842
e-mail: info@mcmweb.it
www.mcmweb.it
MCM 2019 first 12pag 0718 GB OK.indd 12 07/08/18 09.41You can also read
